Expression of hypoxia inducible factor 1 α and Von Hippel Lindau protein in human middle ear cholesteatoma

被引:14
|
作者
Adunka, O [1 ]
Gstoettner, W [1 ]
Knecht, R [1 ]
Kierner, AC [1 ]
机构
[1] Univ Frankfurt Klinikum, Dept Otorhinolaryngol, D-60590 Frankfurt, Germany
来源
LARYNGOSCOPE | 2003年 / 113卷 / 07期
关键词
cholesteatoma; hypoxia inducible factor 1; Von Hippel Lindau protein;
D O I
10.1097/00005537-200307000-00018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To evaluate the role of hypoxia in cholesteatoma progression. Study Design: Immunohistochemical analysis of paraffin-embedded human specimens. Methods: Thirteen middle ear cholesteatomas and 10 samples of normal human external ear canal skin were stained immunohistochemically for the presence of hypoxia inducible factor 1 alpha (HIF 1 alpha) and Von Hippel Lindau. protein. Specimens were then analyzed semiquantitatively. Results: Staining for both antibodies could be detected in all cholesteatomas (perimatrix and matrix), as well as in the samples of normal human ear canal skin. Cholesteatoma specimens showed statistically significant increased staining when compared with normal human skin and mucosa. The age of patients and relapse surgery affected immunohistochemical staining of HIF 1 alpha and Von Hippel Lindau protein. Conclusions: Elevated staining intensities for HIF 1 alpha and Von Hippel Lindau protein in cholesteatoma tissue indicated that cholesteatoma may be bypoxic. In addition, our data indicated that relapse cholesteatomas yield a higher degree of hypoxia than ears without surgery.
引用
收藏
页码:1210 / 1215
页数:6
相关论文
共 50 条
  • [31] Expression of hypoxia-inducible factors in human renal cancer: Relationship to angiogenesis and to the von Hippel-Lindau gene mutation
    Turner, KJ
    Moore, JW
    Jones, A
    Taylor, CF
    Cuthbert-Heavens, D
    Han, C
    Leek, RD
    Gatter, KC
    Maxwell, PH
    Ratcliffe, PJ
    Cranston, D
    Harris, AL
    CANCER RESEARCH, 2002, 62 (10) : 2957 - 2961
  • [32] Regression of solid tumors by engineered overexpression of von Hippel-Lindau tumor suppressor protein and antisense hypoxia-inducible factor-1α
    Sun, X
    Kanwar, JR
    Leung, E
    Vale, M
    Krissansen, GW
    GENE THERAPY, 2003, 10 (25) : 2081 - 2089
  • [33] Proline hydroxylation at different sites in hypoxia-inducible factor 1α modulates its interactions with the von Hippel-Lindau tumor suppressor protein
    Qian, Hongsheng
    Zou, Yu
    Tang, Yiming
    Gong, Yehong
    Qian, Zhenyu
    Wei, Guanghong
    Zhang, Qingwen
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2018, 20 (27) : 18756 - 18765
  • [34] Expression of von Hippel-Lindau protein in normal and pathological human tissues
    Sakashita, N
    Takeya, M
    Kishida, T
    Stackhouse, TM
    Zbar, B
    Takahashi, K
    HISTOCHEMICAL JOURNAL, 1999, 31 (02): : 133 - 144
  • [35] Clusterin is a secreted marker for a hypoxia-inducible factor- independent function of the von Hippel-Lindau tumor suppressor protein
    Nakamura, E
    Abreu-e-Lima, P
    Awakura, Y
    Inoue, T
    Kamoto, T
    Ogawo, O
    Kotani, H
    Manabe, T
    Zhang, GJ
    Kondo, K
    Nosé, V
    Kaelin, WG
    AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (02): : 574 - 584
  • [36] Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease
    Wiley, Henry E.
    Srinivasan, Ramaprasad
    Maranchie, Jodi K.
    Chhablani, Jay
    Iversen, Ane Bundsbaek Bondergaard
    Kruse, Anders
    Jonasch, Eric
    Gombos, Dan S.
    Else, Tobias
    Demirci, Hakan
    Maughan, Benjamin L.
    Hartnett, M. Elizabeth
    Coleman, Hanna R.
    Fu, Wei
    Perini, Rodolfo F.
    Liu, Yanfang
    Linehan, W. Marston
    Chew, Emily Y.
    OPHTHALMOLOGY, 2024, 131 (11) : 1324 - 1332
  • [37] Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau
    Roberts, Andrew M.
    Ohh, Michael
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (01) : 83 - 89
  • [38] Aberrant ubiquitination of hypoxia inducible factor-A by the von Hippel Lindau mutant R200W
    Maranchie, JK
    Jensen, JP
    Klausner, RD
    Weissman, AM
    Linehan, WM
    JOURNAL OF UROLOGY, 2003, 169 (04): : 147 - 147
  • [39] Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma:: Association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1α
    Kuwai, T
    Kitadai, Y
    Tanaka, S
    Hiyama, T
    Tanimoto, K
    Chayama, K
    CANCER SCIENCE, 2004, 95 (02): : 149 - 153
  • [40] Quantifying the Binding Interaction between the Hypoxia-Inducible Transcription Factor and the von Hippel-Lindau Suppressor
    Domene, Carmen
    Jorgensen, Christian
    Vanommeslaeghe, Kenno
    Schofield, Christopher J.
    MacKerell, Alexander, Jr.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2015, 11 (08) : 3946 - 3954